At the time of writing, Opus Genetics Inc [IRD] stock is trading at $2.14, down -6.96%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IRD shares have gain 7.00% over the last week, with a monthly amount glided 13.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Opus Genetics Inc [NASDAQ: IRD] stock has seen the most recent analyst activity on October 29, 2025, when Wedbush initiated its Outperform rating and assigned the stock a price target of $8. Previously, Chardan Capital Markets started tracking the stock with Buy rating on October 16, 2025, and set its price target to $9. On April 11, 2025, Craig Hallum initiated with a Buy rating and assigned a price target of $6 on the stock.
For the past year, the stock price of Opus Genetics Inc fluctuated between $0.65 and $2.30. Opus Genetics Inc [NASDAQ: IRD] shares were valued at $2.14 at the most recent close of the market.
Analyzing the IRD fundamentals
According to Opus Genetics Inc [NASDAQ:IRD], the company’s sales were 15.42M for trailing twelve months, which represents an 159.17% jump. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at -4.21%, Pretax Profit Margin comes in at -3.78%, and Net Profit Margin reading is -3.78%. To continue investigating profitability, this company’s Return on Assets is posted at -1.51, Equity is -3.67 and Total Capital is -3.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.04 points at the first support level, and at 1.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.31, and for the 2nd resistance point, it is at 2.47.
Ratios To Look Out For
It is important to note that Opus Genetics Inc [NASDAQ:IRD] has a current ratio of 1.90. In addition, the Quick Ratio stands at 1.90 and the Cash Ratio stands at 1.61. Considering the valuation of this stock, the price to sales ratio is 8.31, the price to book ratio is 7.34.
Transactions by insiders
Recent insider trading involved Magrath George, Chief Executive Officer, that happened on Dec 26 ’24 when 100000.0 shares were purchased. President, YERXA BENJAMIN R completed a deal on Nov 21 ’24 to buy 10000.0 shares. Meanwhile, Chief Executive Officer Magrath George bought 90294.0 shares on Nov 15 ’24.
